The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Fibrocystic Breast Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fibrocystic Breast Disease


High impact information on Fibrocystic Breast Disease


Chemical compound and disease context of Fibrocystic Breast Disease


Biological context of Fibrocystic Breast Disease


Anatomical context of Fibrocystic Breast Disease


Gene context of Fibrocystic Breast Disease


Analytical, diagnostic and therapeutic context of Fibrocystic Breast Disease


  1. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. Boyle, C.A., Berkowitz, G.S., LiVolsi, V.A., Ort, S., Merino, M.J., White, C., Kelsey, J.L. J. Natl. Cancer Inst. (1984) [Pubmed]
  2. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmunoassayable prolactin and growth hormone and bioactive lactogenic hormones. Rose, D.P., Cohen, L.A., Berke, B., Boyar, A.P. J. Natl. Cancer Inst. (1987) [Pubmed]
  3. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid. Collette, J., Hendrick, J.C., Jaspar, J.M., Franchimont, P. Cancer Res. (1986) [Pubmed]
  4. Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinomas, as measured by RT-PCR. Onisto, M., Riccio, M.P., Scannapieco, P., Caenazzo, C., Griggio, L., Spina, M., Stetler-Stevenson, W.G., Garbisa, S. Int. J. Cancer (1995) [Pubmed]
  5. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast. Joshi, M.G., Lee, A.K., Pedersen, C.A., Schnitt, S., Camus, M.G., Hughes, K.S. Mod. Pathol. (1996) [Pubmed]
  6. Vitamin E relieves most cystic breast disease; may alter lipids, hormones. González, E.R. JAMA (1980) [Pubmed]
  7. Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. Rose, D.P., Boyar, A.P., Cohen, C., Strong, L.E. J. Natl. Cancer Inst. (1987) [Pubmed]
  8. Endocrine parameters and alpha-tocopherol therapy of patients with mammary dysplasia. London, R.S., Sundaram, G.S., Schultz, M., Nair, P.P., Goldstein, P.J. Cancer Res. (1981) [Pubmed]
  9. Fibrocystic breast disease following treatment with selective serotonin reuptake inhibitors. McKenzie, L.J., Risch, S.C. The American journal of psychiatry. (1995) [Pubmed]
  10. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia. Warner, M.R., Warner, R.L. J. Natl. Cancer Inst. (1975) [Pubmed]
  11. Theophylline and fibrocystic breast disease. Hindi-Alexander, M.C., Zielezny, M.A., Montes, N., Bullough, B., Middleton, E., Rosner, D.H., London, W.M. J. Allergy Clin. Immunol. (1985) [Pubmed]
  12. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells. Cassoni, P., Sapino, A., Haagensen, D.E., Naldoni, C., Bussolati, G. Int. J. Cancer (1995) [Pubmed]
  13. Conjugated estrogens and fibrocystic breast disease. Jick, S.S., Walker, A.M., Jick, H. Am. J. Epidemiol. (1986) [Pubmed]
  14. Tamoxifen-induced regression of benign breast lesions. Ricciardi, I., Ianniruberto, A. Obstetrics and gynecology. (1979) [Pubmed]
  15. HLA and prognostic factors in primary breast cancer. Iaffaioli, R.V., Maio, M., Ruggiero, G., De Felice, M., Ungaro, A., Del Vecchio, L., Rosato, G.B., Bianco, A.R., Zappacosta, S. Int. J. Cancer (1985) [Pubmed]
  16. Estrogen replacement therapy and fibrocystic breast disease. Pastides, H., Najjar, M.A., Kelsey, J.L. American journal of preventive medicine. (1987) [Pubmed]
  17. Primary cultures of human benign mastopathies and mammary carcinomas; growth factor requirements. Salle, V., Raux, H., Souttou, B., Israel, L., Crépin, M. Anticancer Res. (1991) [Pubmed]
  18. Enhanced expression of PP1 gamma 1, a catalytic subunit isoform of protein phosphatase type 1, in invasive ductal carcinoma of the breast. Sogawa, K., Masaki, T., Miyauchi, A., Sugita, A., Kito, K., Ueda, N., Miyamoto, K., Okazaki, K., Okutani, K., Matsumoto, K. Cancer Lett. (1997) [Pubmed]
  19. Effect of natural "micronized" progesterone on the chorionic gonadotropin concentrations in cyst fluids of women with gross cystic breast disease. Enriori, P.J., Hirsig, R.J., Vico, C.M., Etkin, A.E., Negri, J.C., Enriori, C.L. J. Steroid Biochem. Mol. Biol. (2000) [Pubmed]
  20. Effects of sex steroids on the development of 7,12-dimethylbenz[a]anthracene-induced mammary dysplasia in neonatally androgenized female rats. Yoshida, H., Fukunishi, R. Gann = Gan. (1981) [Pubmed]
  21. Expression of connexin 43 in breast cancer in comparison with mammary dysplasia and the normal mammary gland. Kańczuga-Koda, L., Sulkowska, M., Koda, M., Reszeć, J., Famulski, W., Baltaziak, M., Sulkowski, S. Folia morphologica. (2003) [Pubmed]
  22. Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors. Lu, S., Shen, K., Wang, Y., Santner, S.J., Chen, J., Brooks, S.C., Wang, Y.A. Carcinogenesis (2006) [Pubmed]
  23. Immunohistochemical profile and differential diagnosis of microglandular adenosis. Tavassoli, F.A., Bratthauer, G.L. Mod. Pathol. (1993) [Pubmed]
  24. Serum prolactin levels in patients with fibrocystic breast disease. Peters, F., Schuth, W., Scheurich, B., Breckwoldt, M. Obstetrics and gynecology. (1984) [Pubmed]
  25. Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma. Shousha, S., Lyssiotis, T. Histopathology (1978) [Pubmed]
  26. Prospective study of "fibrocystic breast disease" and caffeine consumption. Heyden, S., Muhlbaier, L.H. Surgery (1984) [Pubmed]
WikiGenes - Universities